Fluoxymesterone | hsa00030 | Pentose phosphate pathway | 8.97E-03 | 1 | P11413 | G6PD | More | |
Fluoxymesterone | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
Fluoxymesterone | hsa00220 | Arginine biosynthesis | 1.94E-03 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | |
Fluoxymesterone | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.32E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | |
Fluoxymesterone | hsa00480 | Glutathione metabolism | 1.35E-02 | 1 | P11413 | G6PD | More | |
Fluoxymesterone | hsa00500 | Starch and sucrose metabolism | 2.45E-05 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
Fluoxymesterone | hsa00600 | Sphingolipid metabolism | 3.76E-02 | 1 | P15289 | ARSA | More | |
Fluoxymesterone | hsa00730 | Thiamine metabolism | 5.11E-05 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
Fluoxymesterone | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
Fluoxymesterone | hsa00910 | Nitrogen metabolism | 4.32E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | |
Fluoxymesterone | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | |
Fluoxymesterone | hsa01100 | Metabolic pathways | 4.43E-02 | 23 | Q9NR34, P05089, P32320, P22748, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737 | MAN1C1, ARG1, CDA, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL | More | |
Fluoxymesterone | hsa01200 | Carbon metabolism | 2.91E-02 | 1 | P11413 | G6PD | More | |
Fluoxymesterone | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.43E-02 | 1 | P50213 | IDH3A | More | |
Fluoxymesterone | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | |
Fluoxymesterone | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04014 | Ras signaling pathway | 3.65E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04015 | Rap1 signaling pathway | 5.18E-04 | 3 | P08069, P06213, O00522 | IGF1R, INSR, KRIT1 | More | |
Fluoxymesterone | hsa04062 | Chemokine signaling pathway | 3.13E-02 | 8 | P25024, P25025, P07948, P42338, P63218, P50151, P49407, P49841 | CXCR1, CXCR2, LYN, PIK3CB, GNG5, GNG10, ARRB1, GSK3B | More | |
Fluoxymesterone | hsa04064 | NF-kappa B signaling pathway | 1.14E-03 | 11 | Q13489, O00463, Q13546, P14778, Q9UDY8, Q13077, Q16548, Q8WV28, P24522, P09341, Q9UNE0 | BIRC3, TRAF5, RIPK1, IL1R1, MALT1, TRAF1, BCL2A1, BLNK, GADD45A, CXCL1, EDAR | More | |
Fluoxymesterone | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 3 | Q9H228, P01375, Q9UQC2 | EDG8, TNF, GAB2 | More | |
Fluoxymesterone | hsa04114 | Oocyte meiosis | 3.19E-03 | 5 | P51812, Q02750, P16298, Q17RY0, P08069 | RPS6KA3, MAP2K1, PPP3CB, CPEB4, IGF1R | More | |
Fluoxymesterone | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
Fluoxymesterone | hsa04140 | Autophagy - animal | 2.82E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04141 | Protein processing in endoplasmic reticulum | 2.78E-02 | 3 | P07384, O95487, O95816 | CAPN1, SEC24B, BAG2 | More | |
Fluoxymesterone | hsa04150 | mTOR signaling pathway | 2.74E-03 | 7 | P08069, P42338, Q02750, Q9NQL2, P51812, Q13322, P49841 | IGF1R, PIK3CB, MAP2K1, RRAGD, RPS6KA3, GRB10, GSK3B | More | |
Fluoxymesterone | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | |
Fluoxymesterone | hsa04211 | Longevity regulating pathway | 1.34E-03 | 4 | Q12778, P08069, Q9UEF7, Q96KQ7 | FOXO1, IGF1R, KL, EHMT2 | More | |
Fluoxymesterone | hsa04213 | Longevity regulating pathway - multiple species | 2.83E-03 | 3 | P08069, Q9Y4H2, Q13547 | IGF1R, IRS2, HDAC1 | More | |
Fluoxymesterone | hsa04217 | Necroptosis | 1.85E-03 | 7 | P01375, P01568, P48023, Q13489, Q13546, Q14765, Q99878 | TNF, IFNA21, FASLG, BIRC3, RIPK1, STAT4, H2AC14 | More | |
Fluoxymesterone | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | |
Fluoxymesterone | hsa04360 | Axon guidance | 1.50E-02 | 3 | P20827, P23528, Q06124 | EFNA1, CFL1, PTPN11 | More | |
Fluoxymesterone | hsa04370 | VEGF signaling pathway | 2.68E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | |
Fluoxymesterone | hsa04380 | Osteoclast differentiation | 4.71E-02 | 6 | Q16539, P06239, P42338, P14778, O75015, Q8N149 | MAPK14, LCK, PIK3CB, IL1R1, FCGR3B, LILRA2 | More | |
Fluoxymesterone | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04530 | Tight junction | 2.08E-02 | 3 | P63261, Q9Y478, Q92974 | ACTG1, PRKAB1, ARHGEF2 | More | |
Fluoxymesterone | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04613 | Neutrophil extracellular trap formation | 1.23E-03 | 5 | P11215, Q13547, P58876, Q16778, O60814 | ITGAM, HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | |
Fluoxymesterone | hsa04620 | Toll-like receptor signaling pathway | 4.16E-02 | 2 | Q13546, P01568 | RIPK1, IFNA21 | More | |
Fluoxymesterone | hsa04621 | NOD-like receptor signaling pathway | 4.72E-02 | 3 | P01568, Q13489, Q13546 | IFNA21, BIRC3, RIPK1 | More | |
Fluoxymesterone | hsa04622 | RIG-I-like receptor signaling pathway | 2.39E-02 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | |
Fluoxymesterone | hsa04623 | Cytosolic DNA-sensing pathway | 2.20E-03 | 2 | P01568, Q13546 | IFNA21, RIPK1 | More | |
Fluoxymesterone | hsa04650 | Natural killer cell mediated cytotoxicity | 2.94E-02 | 3 | P16298, P50591, Q02750 | PPP3CB, TNFSF10, MAP2K1 | More | |
Fluoxymesterone | hsa04657 | IL-17 signaling pathway | 5.03E-03 | 6 | O00463, Q16539, P49841, P09341, P14780, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, TNF | More | |
Fluoxymesterone | hsa04658 | Th1 and Th2 cell differentiation | 2.71E-03 | 7 | P07766, P20963, Q16539, P01730, P06239, Q9UL17, Q13761 | CD3E, CD247, MAPK14, CD4, LCK, TBX21, RUNX3 | More | |
Fluoxymesterone | hsa04659 | Th17 cell differentiation | 1.05E-02 | 7 | Q16539, P01730, P06239, P14778, Q9UL17, P07766, P20963 | MAPK14, CD4, LCK, IL1R1, TBX21, CD3E, CD247 | More | |
Fluoxymesterone | hsa04660 | T cell receptor signaling pathway | 2.27E-02 | 7 | P42338, P07766, P20963, P01730, P06239, Q16539, P49841 | PIK3CB, CD3E, CD247, CD4, LCK, MAPK14, GSK3B | More | |
Fluoxymesterone | hsa04662 | B cell receptor signaling pathway | 2.80E-03 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | |
Fluoxymesterone | hsa04664 | Fc epsilon RI signaling pathway | 1.80E-02 | 4 | Q16539, P42338, P07948, P09917 | MAPK14, PIK3CB, LYN, ALOX5 | More | |
Fluoxymesterone | hsa04714 | Thermogenesis | 1.25E-02 | 3 | P15336, P63261, Q9Y478 | ATF2, ACTG1, PRKAB1 | More | |
Fluoxymesterone | hsa04720 | Long-term potentiation | 1.38E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | |
Fluoxymesterone | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | |
Fluoxymesterone | hsa04723 | Retrograde endocannabinoid signaling | 3.86E-02 | 4 | P63218, P50151, P48058, Q16539 | GNG5, GNG10, GRIA4, MAPK14 | More | |
Fluoxymesterone | hsa04724 | Glutamatergic synapse | 7.09E-03 | 5 | P48058, P43003, P63218, P50151, P15104 | GRIA4, SLC1A3, GNG5, GNG10, GLUL | More | |
Fluoxymesterone | hsa04728 | Dopaminergic synapse | 2.35E-02 | 6 | P63218, P50151, P49841, Q16539, P49407, P48058 | GNG5, GNG10, GSK3B, MAPK14, ARRB1, GRIA4 | More | |
Fluoxymesterone | hsa04730 | Long-term depression | 1.16E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | |
Fluoxymesterone | hsa04913 | Ovarian steroidogenesis | 8.40E-04 | 2 | P06213, P08069 | INSR, IGF1R | More | |
Fluoxymesterone | hsa04914 | Progesterone-mediated oocyte maturation | 5.89E-03 | 4 | P08069, Q17RY0, P51812, Q02750 | IGF1R, CPEB4, RPS6KA3, MAP2K1 | More | |
Fluoxymesterone | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | |
Fluoxymesterone | hsa04920 | Adipocytokine signaling pathway | 2.80E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | |
Fluoxymesterone | hsa04923 | Regulation of lipolysis in adipocytes | 3.76E-02 | 1 | P06213 | INSR | More | |
Fluoxymesterone | hsa04930 | Type II diabetes mellitus | 3.14E-02 | 1 | P06213 | INSR | More | |
Fluoxymesterone | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | |
Fluoxymesterone | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | |
Fluoxymesterone | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Fluoxymesterone | hsa04960 | Aldosterone-regulated sodium reabsorption | 3.14E-02 | 1 | P06213 | INSR | More | |
Fluoxymesterone | hsa04973 | Carbohydrate digestion and absorption | 1.57E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | |
Fluoxymesterone | hsa04975 | Fat digestion and absorption | 2.80E-02 | 1 | O14494 | PLPP1 | More | |
Fluoxymesterone | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | |
Fluoxymesterone | hsa05034 | Alcoholism | 2.10E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | |
Fluoxymesterone | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.61E-03 | 5 | Q16539, P09341, P25024, P25025, P07948 | MAPK14, CXCL1, CXCR1, CXCR2, LYN | More | |
Fluoxymesterone | hsa05130 | Pathogenic Escherichia coli infection | 9.80E-03 | 4 | Q92974, P63261, Q06124, O95487 | ARHGEF2, ACTG1, PTPN11, SEC24B | More | |
Fluoxymesterone | hsa05132 | Salmonella infection | 9.85E-03 | 4 | Q13546, Q13489, O60282, P68371 | RIPK1, BIRC3, KIF5C, TUBB2C | More | |
Fluoxymesterone | hsa05135 | Yersinia infection | 9.51E-03 | 6 | P13612, P06239, Q16539, P42338, P49841, P01730 | ITGA4, LCK, MAPK14, PIK3CB, GSK3B, CD4 | More | |
Fluoxymesterone | hsa05140 | Leishmaniasis | 2.69E-02 | 5 | O75015, P13765, O60603, P49006, Q16539 | FCGR3B, HLA-DOB, TLR2, MARCKSL1, MAPK14 | More | |
Fluoxymesterone | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
Fluoxymesterone | hsa05146 | Amoebiasis | 4.55E-02 | 5 | P09341, P14778, P27930, O60603, P05089 | CXCL1, IL1R1, IL1R2, TLR2, ARG1 | More | |
Fluoxymesterone | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
Fluoxymesterone | hsa05163 | Human cytomegalovirus infection | 4.78E-04 | 11 | P42338, P63218, P50151, Q14643, P49841, P14778, Q13651, P25025, Q16539, P04637, O00463 | PIK3CB, GNG5, GNG10, ITPR1, GSK3B, IL1R1, IL10RA, CXCR2, MAPK14, TP53, TRAF5 | More | |
Fluoxymesterone | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.94E-02 | 4 | P62879, P16298, Q02750, P0CG47 | GNB2, PPP3CB, MAP2K1, UBB | More | |
Fluoxymesterone | hsa05169 | Epstein-Barr virus infection | 2.32E-02 | 9 | Q13547, O00463, Q16539, P42338, P07948, Q13761, P24522, P07766, P20963 | HDAC1, TRAF5, MAPK14, PIK3CB, LYN, RUNX3, GADD45A, CD3E, CD247 | More | |
Fluoxymesterone | hsa05170 | Human immunodeficiency virus 1 infection | 6.02E-03 | 5 | Q02750, P62879, P16298, Q05397, P20333 | MAP2K1, GNB2, PPP3CB, PTK2, TNFRSF1B | More | |
Fluoxymesterone | hsa05202 | Transcriptional misregulation in cancer | 8.55E-04 | 5 | P27930, P11215, P08069, Q13547, P12980 | IL1R2, ITGAM, IGF1R, HDAC1, LYL1 | More | |
Fluoxymesterone | hsa05203 | Viral carcinogenesis | 6.44E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | |
Fluoxymesterone | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | |
Fluoxymesterone | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | |
Fluoxymesterone | hsa05214 | Glioma | 9.95E-03 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | |
Fluoxymesterone | hsa05224 | Breast cancer | 1.24E-02 | 5 | P08069, P49841, Q92837, P04637, P24522 | IGF1R, GSK3B, FRAT1, TP53, GADD45A | More | |
Fluoxymesterone | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | |
Fluoxymesterone | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | |
Fluoxymesterone | hsa05230 | Central carbon metabolism in cancer | 1.12E-02 | 1 | P11413 | G6PD | More | |
Fluoxymesterone | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.72E-03 | 9 | P42338, O95267, P07766, P20963, P09693, P06239, O60603, Q16539, P01730 | PIK3CB, RASGRP1, CD3E, CD247, CD3G, LCK, TLR2, MAPK14, CD4 | More | |
Fluoxymesterone | hsa05322 | Systemic lupus erythematosus | 1.18E-02 | 3 | P58876, Q16778, O60814 | H2BC5, HIST2H2BE, H2BC12 | More | |
Fluoxymesterone | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Fluoxymesterone | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Fluoxymesterone | hsa05415 | Diabetic cardiomyopathy | 3.59E-02 | 1 | P11413 | G6PD | More | |
Fluoxymesterone | hsa05418 | Fluid shear stress and atherosclerosis | 2.62E-02 | 6 | Q16539, P10599, P14780, P04637, P14778, P27930 | MAPK14, TXN, MMP9, TP53, IL1R1, IL1R2 | More | |